Table 3 of Xu, Mol Vis 2019; 25:834-842.


Table 3. Frequencies of alleles and genotypes of PRKCQ and REL polymorphisms in VKH patients and controls in the first-stage study.

SNP Genotype allele Cases(n=600) Controls(n=1000) P value Pc OR (95% CI)
rs4750316 GG 554 (92.33) 842 (84.2)     Reference
  GC 44 (7.33) 153 (15.3) 2.50e-6 6.00e-5 0.44 (0.31–0.62)
  CC 2 (0.34) 5 (0.5) 0.55 NS 0.61 (0.12–3.14)
  G 1152 (96.00) 1837(91.85)     Reference
  C 48 (4.00) 163 (8.15) 4.66e-6 1.12e-4 0.47 (0.34–0.65)
rs11258747 GG 549 (91.50) 867 (86.7)     Reference
  GT 49 (8.20) 131 (13.1) 0.0026 NS 0.59 (0.42–0.83)
  TT 2 (0.30) 2 (0.2) 0.65 NS 1.58 (0.22–11.24)
  G 1147 (95.60) 1865 (93.30)     Reference
  T 53 (4.40) 135 (6.8) 0.0066 NS 0.64 (0.46–0.88)
rs947474 AA 379(63.17) 686 (68.60)     Reference
  AG 204 (34.00) 287 (28.70) 0.024 NS 1.29 (1.03–1.60)
  GG 17 (2.83) 27 (2.70) 0.68 NS 1.14 (0.61–2.12)
  A 962 (80.17) 1659 (82.95)     Reference
  G 238 (19.83) 341 (17.05) 0.048 NS 1.20 (1.00–1.45)
rs842647 GG 456 (76.00) 759 (75.90)     Reference
  GA 135 (22.50) 222 (22.20) 0.92 NS 1.01 (0.79–1.29)
  AA 9 (1.50) 19 (1.90) 0.56 NS 0.79 (0.35–1.76)
  G 1047 (87.25) 1740 (87.00)     Reference
  A 153 (12.75) 260 (13.00) 0.84 NS 0.98 (0.79–1.21)
rs702873 GG 418 (69.67) 732 (73.20)     Reference
  AG 165 (27.50) 241 (24.10) 0.12 NS 1.20 (0.95–1.51)
  AA 17 (2.83) 27 (2.70) 0.76 NS 1.10 (0.59–2.05)
  G 1001 (83.42) 1705 (85.25)     Reference
  A 199 (16.58) 295 (14.75) 0.17 NS 1.15 (0.94–1.40)
rs13031237 GG 570 (95.00) 962 (96.20)     Reference
  GT 27 (4.50) 38 (3.80) 0.48 NS 1.20 (0.72–1.99)
  TT 3 (0.50) 0 (0) 0.025 NS 2.69 (2.52–2.87)
  G 1167 (97.25) 1962 (98.10)     Reference
  T 33 (2.75) 38 (1.90) 0.11 NS 1.46 (0.91–2.34)